Opyl’s TrialKey achieves major milestone with potential to improve clinical trial success rates - STΟCKHEAD
The current focus does seem to be around TrialKey and using AI to predict trial success, probably the most notable thing is that the article above and company announcements of this tech predate the launch of ChatGPT and recent AI wave of interest.
So its following on from what they were already doing, vs chasing a trend.
Still a tiny market cap, but certainly lots to prove to get market to regain trust again.
Opyl’s TrialKey achieves major milestone with potential to...
Add OPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.218M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 798533 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 62197 | 1 |
View Market Depth
| Last trade - 16.12pm 03/05/2024 (20 minute delay) ? |
| OPL (ASX) Chart |
Day chart unavailable